{"id":97639,"date":"2022-10-01T02:18:43","date_gmt":"2022-10-01T02:18:43","guid":{"rendered":"https:\/\/assignmenttutors.net\/blog\/focused-soap-note-for-schizophrenia-spectrum-other-psychotic-and\/"},"modified":"2023-05-10T09:36:35","modified_gmt":"2023-05-10T09:36:35","slug":"focused-soap-note-for-schizophrenia-spectrum-other-psychotic-and","status":"publish","type":"post","link":"https:\/\/assignmenttutors.net\/blog\/focused-soap-note-for-schizophrenia-spectrum-other-psychotic-and\/","title":{"rendered":"Focused soap note for schizophrenia spectrum, other psychotic, and"},"content":{"rendered":"<div>\n<p><u>Assignment: Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders<\/u><\/p>\n<p>For this Assignment, you will complete a focused SOAP note for a patient in a case study who has either a schizophrenia spectrum, other psychotic, or medication-induced movement disorder.<\/p>\n<h4><u><strong>To Prepare<\/strong><\/u><\/h4>\n<ul>\n<li>Review this \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0week\u2019s Learning Resources. Consider the insights they provide about \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0assessing, diagnosing, and treating schizophrenia spectrum, other \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0psychotic, and medication-induced movement disorders.<\/li>\n<li>Review the \u00a0\u00a0\u00a0\u00a0\u00a0Focused SOAP Note template, which you will use to complete this \u00a0\u00a0\u00a0\u00a0\u00a0Assignment. There is also a Focused SOAP Note Exemplar provided as a guide \u00a0\u00a0\u00a0\u00a0\u00a0for Assignment expectations.<\/li>\n<li>Review the \u00a0\u00a0\u00a0\u00a0\u00a0video, <em>Case Study: Sherman Tremaine<\/em>. You will use this case as \u00a0\u00a0\u00a0\u00a0\u00a0the basis of this Assignment. In this video, a Walden faculty member is \u00a0\u00a0\u00a0\u00a0\u00a0assessing a mock patient. The patient will be represented onscreen as an \u00a0\u00a0\u00a0\u00a0\u00a0avatar.<\/li>\n<li>Consider what \u00a0\u00a0\u00a0\u00a0\u00a0history would be necessary to collect from this patient.<\/li>\n<li>Consider what \u00a0\u00a0\u00a0\u00a0\u00a0interview questions you would need to ask this patient.<\/li>\n<\/ul>\n<h4><strong>The Assignment<\/strong><\/h4>\n<p>Develop a focused SOAP note, including your differential diagnosis and critical-thinking process to formulate a primary diagnosis. Incorporate the following into your responses in the template:<\/p>\n<ul>\n<li><strong>Subjective: <\/strong>What details \u00a0\u00a0\u00a0\u00a0\u00a0did the patient provide regarding their chief complaint and symptomology \u00a0\u00a0\u00a0\u00a0\u00a0to derive your differential diagnosis? What is the duration and severity \u00a0\u00a0\u00a0\u00a0\u00a0of their symptoms? How are their symptoms impacting their functioning in \u00a0\u00a0\u00a0\u00a0\u00a0life?<\/li>\n<li><strong>Objective: <\/strong>What \u00a0\u00a0\u00a0\u00a0\u00a0observations did you make during the psychiatric assessment?<\/li>\n<li><strong>Assessment:<\/strong> Discuss \u00a0\u00a0\u00a0\u00a0\u00a0the patient\u2019s mental status examination results. What were your \u00a0\u00a0\u00a0\u00a0\u00a0differential diagnoses? Provide a minimum of three possible diagnoses with \u00a0\u00a0\u00a0\u00a0\u00a0supporting evidence, and list them in order from highest priority to \u00a0\u00a0\u00a0\u00a0\u00a0lowest priority. Compare the <em>DSM-5-TR<\/em> diagnostic criteria \u00a0\u00a0\u00a0\u00a0\u00a0for each differential diagnosis and explain what <em>DSM-5-TR<\/em> criteria \u00a0\u00a0\u00a0\u00a0\u00a0rules out the differential diagnosis to find an accurate diagnosis. \u00a0\u00a0\u00a0\u00a0\u00a0Explain the critical-thinking process that led you to the primary \u00a0\u00a0\u00a0\u00a0\u00a0diagnosis you selected. Include pertinent positives and pertinent \u00a0\u00a0\u00a0\u00a0\u00a0negatives for the specific patient case.<\/li>\n<li><strong>Plan:<\/strong> What is \u00a0\u00a0\u00a0\u00a0\u00a0your plan for psychotherapy? What is your plan for treatment and \u00a0\u00a0\u00a0\u00a0\u00a0management, including alternative therapies? Include pharmacologic and \u00a0\u00a0\u00a0\u00a0\u00a0nonpharmacologic treatments, alternative therapies, and follow-up \u00a0\u00a0\u00a0\u00a0\u00a0parameters, as well as a rationale for this treatment and management \u00a0\u00a0\u00a0\u00a0\u00a0plan. Also incorporate one health promotion activity and one patient \u00a0\u00a0\u00a0\u00a0\u00a0education strategy.<\/li>\n<li><strong>Reflection \u00a0\u00a0\u00a0\u00a0\u00a0notes:<\/strong> What \u00a0\u00a0\u00a0\u00a0\u00a0would you do differently with this patient if you could conduct the \u00a0\u00a0\u00a0\u00a0\u00a0session again? Discuss what your next intervention would be if you \u00a0\u00a0\u00a0\u00a0\u00a0were able to follow up with this patient.\u202fAlso include in your reflection \u00a0\u00a0\u00a0\u00a0\u00a0a discussion related to legal\/ethical considerations (demonstrate critical \u00a0\u00a0\u00a0\u00a0\u00a0thinking beyond confidentiality and consent for treatment!), health \u00a0\u00a0\u00a0\u00a0\u00a0promotion, and disease prevention, taking into consideration patient factors \u00a0\u00a0\u00a0\u00a0\u00a0(such as age, ethnic group, etc.), PMH, and other risk factors (e.g., \u00a0\u00a0\u00a0\u00a0\u00a0socioeconomic, cultural background, etc.).<\/li>\n<li>Provide at \u00a0\u00a0\u00a0\u00a0\u00a0least three evidence-based, peer-reviewed journal articles or \u00a0\u00a0\u00a0\u00a0\u00a0evidenced-based guidelines that relate to this case to support your \u00a0\u00a0\u00a0\u00a0\u00a0diagnostics and differential diagnoses. Be sure they are current (no more \u00a0\u00a0\u00a0\u00a0\u00a0than 5 years old).<\/li>\n<\/ul>\n<p>Medication Review<\/p>\n<p>Review the FDA-approved use of the following medicines related to treating schizophrenia-spectrum and other psychotic disorders:<\/p>\n<p>Psychosis<\/p>\n<p>Schizoaffective \u00a0\u00a0\u00a0disorder<\/p>\n<p>alprazolam (adjunct)<br \/>\namisulpride<br \/>\naripiprazole<br \/>\nasenapine<br \/>\nblonanserin<br \/>\ncarbamazepine (adjunct)<br \/>\nchlorpromazine<br \/>\nclonazepam (adjunct)<br \/>\nclozapine<br \/>\ncyamemazine<br \/>\nflupenthixol<br \/>\nfluphenazine<br \/>\nhaloperidol<br \/>\niloperidone<br \/>\nlamotrigine (adjunct)<br \/>\nlorazepam (adjunct)<br \/>\nloxapine<br \/>\nlurasidone<\/p>\n<p>mesoridazine<br \/>\nmolindone<br \/>\nolanzapine<br \/>\npaliperidone<br \/>\nperospirone<br \/>\nperphenazine<br \/>\npimozide<br \/>\npipothiazine<br \/>\nquetiapine<br \/>\nrisperidone<br \/>\nsertindole<br \/>\nsulpiride<br \/>\nthioridazine<br \/>\nthiothixene<br \/>\ntrifluoperazine<br \/>\nvalproate (divalproex) (adjunct)<br \/>\nziprasidone<br \/>\nzotepine<br \/>\nzuclopenthixol<\/p>\n<p>amisulpride<br \/>\naripiprazole<br \/>\nasenapine<br \/>\ncarbamazepine (adjunct)<br \/>\nchlorpromazine<br \/>\nclozapine<br \/>\ncyamemazine<br \/>\nflupenthixol<br \/>\nhaloperidol<br \/>\niloperidone<br \/>\nlamotrigine (adjunct)<br \/>\nl-methylfolate (adjunct)<br \/>\nloxapine<br \/>\nlurasidone<br \/>\nmesoridazine<br \/>\nmolindone<br \/>\nolanzapine<br \/>\npaliperidone<\/p>\n<p>perospirone<br \/>\nperphenazine<br \/>\npipothiazine<br \/>\nquetiapine<br \/>\nrisperidone<br \/>\nsertindole<br \/>\nsulpiride<br \/>\nthioridazine<br \/>\nthiothixene<br \/>\ntrifluoperazine<br \/>\nvalproate (divalproex) (adjunct)<br \/>\nziprasidone<br \/>\nzotepine<br \/>\nzuclopenthixol<\/p>\n<p>Schizophrenia<\/p>\n<p>Cataplexy syndrome<\/p>\n<p>Catatonia<\/p>\n<p>Extrapyramidal side \u00a0\u00a0\u00a0effects<\/p>\n<p>amisulpride<br \/>\naripiprazole<br \/>\nasenapine<br \/>\ncarbamazepine (adjunct)<br \/>\nchlorpromazine<br \/>\nclozapine<br \/>\ncyamemazine<br \/>\nflupenthixol<br \/>\nhaloperidol<br \/>\niloperidone<br \/>\nlamotrigine (adjunct)<br \/>\nl-methylfolate (adjunct)<br \/>\nloxapine<br \/>\nlurasidone<br \/>\nmesoridazine<br \/>\nmolindone<br \/>\nolanzapine<br \/>\npaliperidone<br \/>\nperospirone<\/p>\n<p>perphenazine<br \/>\npipothiazine<br \/>\nquetiapine<br \/>\nrisperidone<br \/>\nsertindole<br \/>\nsulpiride<br \/>\nthioridazine<br \/>\nthiothixene<br \/>\ntrifluoperazine<br \/>\nvalproate (divalproex) (adjunct)<br \/>\nziprasidone<br \/>\nzotepine<br \/>\nzuclopenthixol<br \/>\nSeasonal affective disorder<br \/>\nbupropion<br \/>\nSedation-induction<br \/>\nhydroxyzine<br \/>\nmidazolam<\/p>\n<p>clomipramine<br \/>\nimipramine<br \/>\nsodiu<\/p>\n<p>Sadock, B. J., Sadock, V. A., &amp; Ruiz, P. (2015). <em>Kaplan &amp; Sadock\u2019s synopsis of psychiatry<\/em> (11th ed.). Wolters Kluwer. (For review as needed)<\/p>\n<ul>\n<li>Chapter 7, \u201cSchizophrenia \u00a0\u00a0\u00a0\u00a0\u00a0Spectrum and Other Psychotic Disorders\u201d<\/li>\n<li>Chapter 29.2, \u00a0\u00a0\u00a0\u00a0\u00a0\u201cMedication-Induced Movement Disorders\u201d<\/li>\n<li>Chapter 29.3, \u201c\u03b12-Adrenergic \u00a0\u00a0\u00a0\u00a0\u00a0Receptor Agonists, \u03b11-Adrenergic Receptor Antagonists: \u00a0\u00a0\u00a0\u00a0\u00a0Clonidine, Guanfacine, Prazosin, and Yohimbine\u201d<\/li>\n<\/ul>\n<p>Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., &amp; Taylor, E. A. (Eds.). (2015). <em>Rutter\u2019s child and adolescent psychiatry<\/em> (6th ed.). Wiley Blackwell.<\/p>\n<p>\u00b7 Chapter 43, \u201cPharmacological, Medically-Led and Related Disorders\u201d<\/p>\n<p>\u00b7 Chapter 57, \u201cSchizophrenia and Psychosis\u201d<\/p>\n<p>Zakhari, R. (2021). <em>The psychiatric-mental health nurse practitioner certification review manual<\/em>. Springer Publishing Company.<\/p>\n<p>\u00b7 Chapter 9, \u201cPsychotic Disorders and Delusions\u201d<\/p>\n<p>REQUIRED MEDIA<\/p>\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=ipW5AcbFzzE\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.youtube.com\/watch?v=ipW5AcbFzzE<\/a><\/p>\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=63lHuGMbscU\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.youtube.com\/watch?v=63lHuGMbscU<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Assignment: Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders For this Assignment, you will complete a focused SOAP note for a patient in a case study who has either a schizophrenia spectrum, other psychotic, or medication-induced movement disorder. To Prepare Review this \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0week\u2019s Learning Resources. Consider the insights they provide about [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[],"class_list":["post-97639","post","type-post","status-publish","format-standard","hentry","category-nursing-healthcare-medicine-nursing"],"_links":{"self":[{"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/posts\/97639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/comments?post=97639"}],"version-history":[{"count":2,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/posts\/97639\/revisions"}],"predecessor-version":[{"id":122631,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/posts\/97639\/revisions\/122631"}],"wp:attachment":[{"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/media?parent=97639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/categories?post=97639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/assignmenttutors.net\/blog\/wp-json\/wp\/v2\/tags?post=97639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}